Literature DB >> 18622275

Expanding the evidence base in transplantation: more and better randomized trials, and extending the value of observational data.

Jonathan C Craig1, Angela C Webster, Andrew Mitchell, Les Irwig.   

Abstract

Transplant registries, despite being complete and large, will always be observational data and subject to potential biases, such as selection bias. Consequently conclusions about the effects of interventions will almost always be uncertain, except when the magnitude is very large, and natural history of a condition homogeneous. Rather than re-running old debates of the outcomes-research movement, it is time for improvements in registries and randomized trials to occur so that effective interventions can be administered to individual patients in whom benefits will outweigh harms.

Entities:  

Mesh:

Year:  2008        PMID: 18622275     DOI: 10.1097/TP.0b013e31817d5095

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  2 in total

Review 1.  Determining the Suitability of Registries for Embedding Clinical Trials in the United States: A Project of the Clinical Trials Transformation Initiative.

Authors:  J Stephen Mikita; Jules Mitchel; Nicolle M Gatto; John Laschinger; James E Tcheng; Emily P Zeitler; Arlene S Swern; E Dawn Flick; Christopher Dowd; Theodore Lystig; Sara B Calvert
Journal:  Ther Innov Regul Sci       Date:  2020-06-22       Impact factor: 1.778

Review 2.  A revisited strategy for antiepileptic drug development in children: designing an initial exploratory step.

Authors:  Catherine Chiron; Behrouz Kassai; Olivier Dulac; Gerard Pons; Rima Nabbout
Journal:  CNS Drugs       Date:  2013-03       Impact factor: 5.749

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.